Daniel Cramer
6Patents
2h-index
12Co-inventors
48Inventor score
Filing activity: Jun 5, 2002 → Dec 28, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7112408B2 | Detection of ovarian cancer based upon alpha-haptoglobin levels | Physics | 6 | Expired |
| US7288383B2 | Eosinophil-derived neurotoxin as a marker for ovarian cancer | Physics | 2 | Expired |
| US11243208B2 | Autoantibody biomarkers for the early detection of ovarian cancer | Emerging Cross-Sectional Technologies | 1 | Active |
| US8642347B2 | Urinary CA125 peptides as biomarkers of ovarian cancer | Chemistry; Metallurgy | 1 | Active |
| US10571400B2 | Plasmonic nanoparticle immunoassay method | Physics | 0 | Active |
| US12196757B2 | Autoantibody biomarkers for the early detection of ovarian cancer | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.